# OnCo record pml (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/pml/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "pml" ;
  schema:name "PML"@en ;
  schema:alternateName "PML nuclear body scaffold"@en, "TRIM19"@en, "RNF71"@en, "PML" ;
  schema:description "PML (PML nuclear body scaffold) is a gene whose normal job is to hold cell growth in check. The public catalogues list it as a drug target, a tumour suppressor, a biomarker and a fusion partner, and an approved or late-stage drug is recorded against it. Tied to Leukaemia, Thyroid cancer, Lung cancer and 3 more."@en ;
  schema:url <https://onco.cc/targets/pml/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:9113>, <https://www.uniprot.org/uniprotkb/P29590/entry>, <https://www.ncbi.nlm.nih.gov/gene/5371>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000140464> ;
  onco:tag "cancer-genes-wave" ;
  onco:targetClass "tumor-suppressor" ;
  schema:sameAs <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:9113>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000140464>, <https://www.uniprot.org/uniprotkb/P29590/entry>, <https://www.ncbi.nlm.nih.gov/gene/5371> ;
  onco:related <https://onco.cc/collections/civic/>, <https://onco.cc/collections/open-targets/>, <https://onco.cc/collections/intogen/> ;
  onco:cancers <https://onco.cc/cancers/leukaemia/>, <https://onco.cc/cancers/thyroid/>, <https://onco.cc/cancers/lung-cancer/>, <https://onco.cc/cancers/skin-cancer/>, <https://onco.cc/cancers/myeloproliferative-neoplasms/>, <https://onco.cc/cancers/apl/> ;
  onco:drugs <https://onco.cc/drugs/arsenic-trioxide/>, <https://onco.cc/drugs/tretinoin-atra/> .